Patent · US Active

ROR1 antibodies

US11466083B2 · kind B2 · utility

2Cited by

2References

19Claims

0Family size

Assignee

UCL Business Ltd · GB

Inventors

Amit Nathwani · London, GB
Satyen Gohil · London, GB
Marco Della Peruta · London, GB

Key dates

Filing date	Jul 5, 2018
Grant date	Oct 11, 2022
Priority date	—
Expiry date	Feb 10, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is described Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1) antibodies that specifically bind a ROR1 polypeptide, and their use. In particular, isolated monoclonal antibodies are described and their use in a number of applications, including in the detection, prevention and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.